Cancer drug for children recommended after becoming cost effective for NHS patients
06 August 2018
NICE reports that around 60% of children with high-risk neuroblastoma could be treated with dinutuximab beta
06 August 2018
NICE reports that around 60% of children with high-risk neuroblastoma could be treated with dinutuximab beta